Mechanisms of Resistance to Quinolones
Top Cited Papers
Open Access
- 15 July 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (Supplement), S120-S126
- https://doi.org/10.1086/428052
Abstract
The increased use of fluoroquinolones has led to increasing resistance to these antimicrobials, with rates of resistance that vary by both organism and geographic region. Resistance to fluoroquinolones typically arises as a result of alterations in the target enzymes (DNA gyrase and topoisomerase IV) and of changes in drug entry and efflux. Mutations are selected first in the more susceptible target: DNA gyrase, in gram-negative bacteria, or topoisomerase IV, in gram-positive bacteria. Additional mutations in the next most susceptible target, as well as in genes controlling drug accumulation, augment resistance further, so that the most-resistant isolates have mutations in several genes. Resistance to quinolones can also be mediated by plasmids that produce the Qnr protein, which protects the quinolone targets from inhibition. Qnr plasmids have been found in the United States, Europe, and East Asia. Although Qnr by itself produces only low-level resistance, its presence facilitates the selection of higher-level resistance mutations, thus contributing to the alarming increase in resistance to quinolones.Keywords
This publication has 61 references indexed in Scilit:
- Quinolone Resistance Mechanisms in PneumococciClinical Infectious Diseases, 2004
- The Epidemiology of Fluoroquinolone‐ResistantNeisseria gonorrhoeaein Hawaii, 2001Clinical Infectious Diseases, 2004
- Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in EnglandJournal of Antimicrobial Chemotherapy, 2003
- In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for TherapyAntimicrobial Agents and Chemotherapy, 2003
- Topoisomerase Targeting with and Resistance to Gemifloxacin in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Cleavable-Complex Formation by Wild-Type and Quinolone-Resistant Streptococcus pneumoniae Type II Topoisomerases Mediated by Gemifloxacin and Other FluoroquinolonesAntimicrobial Agents and Chemotherapy, 2002
- Intrinsic Resistance of Mycobacterium smegmatis to Fluoroquinolones May Be Influenced by New Pentapeptide Protein MfpAAntimicrobial Agents and Chemotherapy, 2001
- Positive R plasmid mutator effect on chromosomal mutation to nalidixic acid resistance in nalidixic acid-exposed cultures of Escherichia coliJournal of Antimicrobial Chemotherapy, 1995
- A Multidrug Resistance Regulatory Chromosomal Locus Is Widespread among Enteric BacteriaThe Journal of Infectious Diseases, 1993
- Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolonesMutagenesis, 1990